DISCOVERY LIFE SCIENCES
LIVE

Serial Number

98237326

Owner

DISCOVERY LIFE SCIENCES, LLC

First Use Date

Oct 16, 2018

Filing Date

Oct 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DISCOVERY LIFE SCIENCES Trademark

Serial Number: 98237326 • Registration: 7638955

DISCOVERY LIFE SCIENCES is a trademark filed by DISCOVERY LIFE SCIENCES, LLC on October 24, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

DISCOVERY LIFE SCIENCES, LLC (19 trademarks)

800 HUDSON WAY, SUITE 1700
HUNTSVILLE, AL 35806

Entity Type: 16

Trademark Details

Filing Date

October 24, 2023

Registration Date

January 7, 2025

First Use Anywhere

October 16, 2018

First Use in Commerce

October 16, 2018

Published for Opposition

November 19, 2024

Goods & Services

Biomedical services, namely, the storage of human biological specimens for medical use

Human hematology and immunology cells for medical and clinical use

Biological tissue, namely, blood, stem cells for scientific, laboratory or medical research, biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; cells for scientific, laboratory or medical research; Cell culture media for scientific and research use; Drug metabolism enzymes for use in toxicological research and pharmaceutical research and development; Enzymes for scientific and research purposes; Cell microsomes for scientific research use; Human and animal primary cells for scientific research; Reagents for research purposes; Reagents for scientific or medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Nutritive substances for microorganism cultures for scientific and clinical research

Medical and scientific research services in the field of biological tissue; Medical and scientific research information in the field of primary cell biology, stem cell biology, toxicology, research reagents, cells, cell culture, and the development of research; Medical research laboratory services, namely, collecting and processing of human and animal hematopoietic and immunological cells; flow cytometry services being scientific and medical research; immunophenotyping services being scientific and medical research; validation of cell separation devices for clinical use being quality control testing; Laboratory scientific research in the field of primary cell biology, stem cell biology, toxicology, research reagents, cell culture, and the development of research tools for same; Scientific research and development and consultation related thereto in the field of primary cell biology, stem cell biology, toxicology, research reagents, cells, cell culture, and the development of research tools for same; Fee-for-service commercial nonclinical sequencing of human genetic material for scientific and medical research purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 7, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 7, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 7, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 7, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 7, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 28, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 28, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 28, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 10, 2024 CNRT
ASSIGNED TO EXAMINER
May 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2023 NWOS
NEW APPLICATION ENTERED
Oct 27, 2023 NWAP